C. Nicholson

C. Nicholson

Direttore/Membro del Consiglio presso ACTINIUM PHARMACEUTICALS, INC.

Patrimonio netto: 420 $ in data 31/05/2026

71 anni
Health Technology
Commercial Services
Finance

Profilo

C.
David Nicholson
is Chairman at Exscientia AI Ltd. since 2020.
Non-Executive Chairman at Wild Bioscience Ltd. since 2023.
Director at Rapalogix Health, Inc., Science Exchange, Inc. since 2018, Tarus Therapeutics, Inc. since 2020, Volastra Therapeutics, Inc., and Gilde Healthcare Partners, Inc. since 2020.
Lead Independent Director at Actinium Pharmaceuticals, Inc. since 2017.
Former Non-Executive Chairman at Exscientia Ltd. from 2023 to 2024.
Vice Chairman at Transcelerate Biopharma, Inc. Former Director at Actinium Pharmaceuticals, Inc. Director at Cactus Ventures, Inc. from 2012 to 2013.
Independent Director at Adverum Biotechnologies, Inc. from 2023 to 2025.
Senior Vice President at Forest Laboratories, Inc. Vice President-Licensing & Knowledge Management at Merck & Co., Inc. from 2009 to 2011.
SVP-Global Project Management & Drug Safety at Schering-Plough Corp.
from 2007 to 2009.
Chief Technology Officer & Executive VP at Bayer CropScience AG from 2012 to 2014.
Executive Vice President-Research & Development at Organon International, Inc. from 1988 to 2007 and at Organon Biosciences, Inc. in 2007.
Executive VP, Chief Research & Development Officer at Allergan UC from 2015 to 2020.
CTO, Head-Research & Development at Bayer Crop Science Solutions LLC from 2012 to 2014.
Education includes an undergraduate degree from The University of Manchester in 1975 and a doctorate from The University of Wales in 1980.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
15/10/2025 333 ( 0% ) 420 $ 31/05/2026

Posizioni attive di C. Nicholson

SocietàPosizioneInizio
ACTINIUM PHARMACEUTICALS, INC. Direttore/Membro del Consiglio 01/01/2008
Direttore/Membro del Consiglio 28/06/2018
Investitore di Private Equity 01/09/2020
Direttore/Membro del Consiglio -
Presidente 03/11/2023
Presidente 01/10/2020
Direttore/Membro del Consiglio 14/05/2020

Precedenti posizioni note di C. Nicholson

SocietàPosizioneFine
ADVERUM BIOTECHNOLOGIES, INC. Direttore/Membro del Consiglio 09/12/2025
EXSCIENTIA PLC Presidente 12/02/2024
░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di C. Nicholson

Formazione di C. Nicholson

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

62

Relazioni di 1° grado

22

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private22

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Consumer Services

Process Industries

Health Technology

Consumer Services

Organon Biosciences, Inc.

Health Technology

Technology Services

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Commercial Services

  1. Mercati
  2. Insiders
  3. C. Nicholson
-40% : Prolongation exceptionnelle ➤➤➤➤
g
:
:
ENTRA ORA